Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

VTGN Vistagen Therapeutics Inc

4,565

0,195 (4,46%)

Zuletzt aktualisiert: 17:06:01

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Vistagen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Vistagen Therapeutics Charts.

Vistagen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Vistagen Therapeutics Charts.

News VistaGen Therapeutics Inc

Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Dienstag 7 Mai 2024 (6 Tage vor) • Business Wire

Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
Donnerstag 25 April 2024 (3 Wochen vor) • Business Wire

Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Dienstag 9 April 2024 (1 Monat vor) • Business Wire

Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Montag 1 April 2024 (1 Monat vor) • Business Wire

Vistagen to Present at Stifel 2024 Virtual CNS Days
Montag 11 März 2024 (2 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 1 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Vistagen to Present at TD Cowen 44th Annual Health Care Conference
Mittwoch 28 Februar 2024 (2 Monate vor) • Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere VistaGen Therapeutics Inc News-Artikel

Deutsche Telekom

Gold vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen